Skip to main content

Ivan Spasojevic

Associate Professor in Medicine
Medicine, Medical Oncology
Box 3839 Med Ctr, Durham, NC 27710
5317 Orange Zone, Duke Hospital South, Durham, NC 27710

Current Duke Appointments & Affiliations


Associate Professor in Medicine · 2021 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 1992 - Present Duke Cancer Institute, Institutes and Centers

Recent Scholarly Works


BMX-001 acts as a selective chemoradioprotector in rectal cancer.

Journal article Redox Biochem Chem · June 2026 Colorectal cancer is a common yet survivable malignancy, partly due to the addition of chemoradiation to treatment regimens. Many patients suffer treatment-related side effects such as pain, diarrhea, and myelosuppression, and increasing tolerance of treat ... Full text Link to item Cite

Treatment with Manganese Porphyrin, MnTnBuOE-2-PyP5+, Suppressed the Activation of Macrophages in a Mouse Intracerebral Hemorrhage.

Journal article Pharmaceuticals (Basel) · April 8, 2025 Background: Manganese porphyrin, MnTnBuOE-2-PyP5+ (BMX-001), improves neurologic deficits in experimental ischemic stroke and has the potential to serve as an adjunct with thrombolysis or thrombectomy in stroke patients. In 10-30% of stroke patients follow ... Full text Link to item Cite

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd).

Journal article Nat Commun · April 2, 2025 Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate (ADC) targeting HER2, exhibiting significant clinical efficacy in breast cancer (BC) with varying HER2 expression, including HER2-low and HER2-ultralow. However, the precise mechanism underlying ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Inhibiting Rev1-mediated DNA translesion synthesis for cancer therapy

ResearchCo Investigator · Awarded by National Cancer Institute · 2024 - 2028

Triacetin Treatment for Propionic Acidemia by Rebalancing the Acetyl-CoA/Propionyl-CoA Metabolism

ResearchCo Investigator · Awarded by National Center for Advancing Translational Sciences · 2024 - 2027

Targeting Apolipoprotein-E to Improve Recovery after Spinal Cord Injury

ResearchCollaborator · Awarded by University of Maryland, Baltimore · 2025 - 2027

View All Grants

Education


Duke University · 1999 Ph.D.